🇺🇸 FDA
Pipeline program

Voriconazole 200mg

2018-014-1

Phase 1 small_molecule active

Quick answer

Voriconazole 200mg for Cryptococcal Meningitis is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Cryptococcal Meningitis
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials